Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia

Sickle cell disease (SCD) is a group of related yet genetically complex hemoglobinopathies. Universal newborn screening (NBS) for SCD is performed in the United States and many other nations. Classical, protein-based laboratory methods are often adequate for the diagnosis of SCD but have specific li...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lisa M. Shook, Deidra Haygood, Charles T. Quinn
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/c1f70e7f65144aefa23176d0bb39f992
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires